2022
DOI: 10.1016/j.cej.2022.137736
|View full text |Cite
|
Sign up to set email alerts
|

Toward Point-of-Care chronic disease Management: Biomarker detection in exhaled breath using an E-Nose sensor based on rGO/SnO2 superstructures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 38 publications
(21 citation statements)
references
References 75 publications
0
21
0
Order By: Relevance
“…When a sensor is exposed to an analyte gas, dissociated gas may preferentially and strongly adsorb at reduced graphene oxide-SnO 2 nanospheres interfaces because these interfaces have high active sites such as vacancies, line defects, and strong electronic interaction between graphene and metal oxides. Under these conditions, the reduced graphene oxide nanosheets acting as electron transporters will accept electrons from the adjacent SnO 2 nanospheres, hence enhancing the sensing response of the sensor [17]. The proposed reduced graphene oxide-SnO 2 nanospheres sensor showed significantly better or comparable sensing performance compared to the reported heptane and decane sensors as shown in Table 1.…”
Section: Resultsmentioning
confidence: 87%
“…When a sensor is exposed to an analyte gas, dissociated gas may preferentially and strongly adsorb at reduced graphene oxide-SnO 2 nanospheres interfaces because these interfaces have high active sites such as vacancies, line defects, and strong electronic interaction between graphene and metal oxides. Under these conditions, the reduced graphene oxide nanosheets acting as electron transporters will accept electrons from the adjacent SnO 2 nanospheres, hence enhancing the sensing response of the sensor [17]. The proposed reduced graphene oxide-SnO 2 nanospheres sensor showed significantly better or comparable sensing performance compared to the reported heptane and decane sensors as shown in Table 1.…”
Section: Resultsmentioning
confidence: 87%
“…Formaldehyde is a common toxic carcinogen in the environment and an important biomarker for LC [34,99]. LC patients have been shown to convert active aldehydes into stable oximes by means of on-fiberderivatization (SPME-OFD) [100].…”
Section: Formaldehydementioning
confidence: 99%
“…Pretreatment processes such as dehumidification and filter are significant to improve the accuracy of breath diagnosis when the resistance property of metal oxide materials cannot meet the requirement. An ideal respiratory gas sensor should have excellent selectivity, moisture Biomarker n-propanol [28] Toluene [29] Isoprene [30,31] Cyclohexane [28] Acetaldehyde [32] Formaldehyde [33,34] resistance, ppb-level detection limit, and high sensitivity. Therefore, it is urgent to develop gas sensing materials with excellent performance to meet the requirements of LC respiratory diagnosis.…”
Section: Introduction mentioning
confidence: 99%
“…Even if the association between a particular illness and certain VOCs has been recognized for more than a century, only current technologies based on semiconductor gas sensors can provide the quantitative measurements required for stringent clinical practice. Clinical experiments have shown the potential for utilizing breath to diagnose major diseases, including many forms of cancer, diabetes, multiple sclerosis, and kidney disease [ 181 ]. The invention and widespread use of solid-state gas sensors have offered an additional boost to the interest in VOC inspection and analysis for medical applications [ 182 ].…”
Section: Potential Biomedical Applicationmentioning
confidence: 99%